HC Wainwright & Co. initiated coverage on Dyadic International with a new price target

12/17/21 6:17:22 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

HC Wainwright & Co. initiated coverage of Dyadic International with a rating of Buy and set a new price target of $7.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DYAI

Date	Price Target	Rating	Analyst
7/18/2022		Buy → Neutral	Dawson James
12/17/2021	$7.00	Buy	HC Wainwright & Co.